Details for 2015834421
Up to date per 11.04.2026
Actions
Details for 2015834421
Granted/Registered
European Patent
28.06.2017 A
01.07.2020 B1
20.08.2014
US
201462039809 P
A61K 38/36 20060101AFI20171212BHEP
Owner
Portola Pharmaceuticals, Inc.270 East Grand Avenue Suite 22 South San Francisco, California 94080US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
WANG, Juan614 Ara Lane Foster City, CA 94404US
SACHA, Gregory A.4271 Whitetail Woods Dr. Bargersville, IN 46106US
NGUYEN, Phuong M.1224 Floribunda Ave Apt. 9 Burlingame, CA 94010US
Information about Fees